7Lee WM.Acetaminophen and the U.S.acute liver failure study group:lowering the risks of hepatic failure.Hepatology,2004,40:6-9.
8Evans DC,Watt AP,Nicoll-Grifith DA,Baillie TA.Drug-protein adducts:an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.Chem Res Toxicol,2004,17:3-16.
9Park BK,Kitteringham NR,Maggs JL,Pirmohamed M,Williams RP.The role of metabolic activation in drug-induced hepatotoxicity.Annu Rev Pharmacol Toxicol,2005,45:177-202.
